Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes

J Neuroimmunol. 1997 Aug;77(2):211-6. doi: 10.1016/s0165-5728(97)00076-3.

Abstract

Interleukin-8 (IL-8) is an important cytokine in inflammatory processes by functioning as a chemoattractant and as an activator of oxygen metabolism. In the present study we demonstrate that beta 2-adrenergic agonists potentiate the lipopolysaccharide (LPS) and IL-1 induced production of IL-8 by human monocytes. In addition, beta 2-adrenergic activation enhances IL-8 release and mRNA expression for IL-8 in the human monocytic cell line U937. beta 2-adrenergic activation of these cells also results in enhanced production of the anti-inflammatory cytokine IL-10. However, IL-10 is not involved in the regulation of IL-8 production. The effect of the beta 2-adrenergic agonist on IL-8 production is presumably mediated via increased cAMP formation, since it can be mimicked by the cAMP analogue dibutyryl-cAMP (db-cAMP). We conclude that enhancement of IL-8 production is one of the pathways via which beta 2-adrenergic agonists such as catecholamines can influence inflammatory responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adrenergic beta-Agonists / pharmacology*
  • Bucladesine / pharmacology
  • Cell Line
  • Humans
  • Interleukin-10 / pharmacology
  • Interleukin-8 / biosynthesis*
  • Interleukin-8 / genetics
  • Kinetics
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Monocytes / metabolism*
  • RNA, Messenger / biosynthesis
  • Receptors, Adrenergic, beta-2 / drug effects
  • Receptors, Adrenergic, beta-2 / metabolism*
  • Terbutaline / pharmacology

Substances

  • Adjuvants, Immunologic
  • Adrenergic beta-Agonists
  • Interleukin-8
  • RNA, Messenger
  • Receptors, Adrenergic, beta-2
  • Interleukin-10
  • Bucladesine
  • Terbutaline